Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(7):557-558; doi:10.1093/jnci/djh111
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Carter, H. B.
Right arrow Articles by Walsh, P. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Carter, H. B.
Right arrow Articles by Walsh, P. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

Prostate-specific Antigen and All-Cause Mortality: Results From the Baltimore Longitudinal Study On Aging

H. Ballentine Carter, E. Jeffrey Metter, James Wright, Patricia Landis, Elizabeth Platz, Patrick C. Walsh

Affiliations of authors: Department of Urology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland (HBC, JW, PL); The Johns Hopkins Bloomberg School of Public Health (EP); National Institute on Aging, Gerontology Research Center (EJM), Baltimore, MD.

Correspondence to: H. Ballentine Carter, Department of Urology, 403 Marburg, The Johns Hopkins Hospital, 600 N. Wolfe St., Baltimore, MD 21287-2101 (e-mail: hcarter@jhmi.edu)

The first 10% of the full text of this article appears below.

Benign prostatic hyperplasia (BPH) and prostate cancer are two common diseases in aging males. Age is the strongest known risk factor for the development of both diseases. The prevalence of BPH and prostate cancer increase exponentially with age (1,2).

Prostate-specific antigen (PSA) is a protein product of the prostate that is a recognized marker of both BPH and prostate cancer. Cross-sectional data suggest . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?